Citations

Showing 10 of 108119 citations.

Between 2000 and 2020, Reimbursement for Orthopaedic Foot and Ankle Surgery Decreased by 30%
Haglin, Jack M. , LeBlanc, Matthew P., Rosenow, Christian S. , Makovicka, Justin L. , Deckey, David G. , Bingham, Joshua S. , Pollock, Jordan Riley , Moore, M. Lane , Hassebrock, Jeffrey D. , Patel, Karan A.

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | December 24, 2021 | Volume: 4 | Issue: 2 | Pages: No page available

10.1016/j.asmr.2021.11.016 | PMID 35494293 Get It

Purpose To examine and analyze Medicare reimbursement rates from 2000 to 2020 for orthopaedic foot and ankle procedures. Methods The 20 most used orthopaedic foot and ankle surgical procedures were gathered from the Centers for Medicare & Medicaid Services website using the Medicare Provider Utilization and Payment Data Public Use File 2017. The reimbursement data for each code were gathered from The Physician Fee Schedule Look‐Up Tool from Centers for Medicare & Medicaid Services. The reimbursement values were adjusted for inflation to 2020 U.S. dollars using the consumer price index. Results The average inflation‐adjusted reimbursement for included procedures decreased by 30% from 2000 to 2020. The greatest mean decreases were observed for “correction of hallux valgus” (–47%) and “partial excision of foot bone” (–41%). The procedures with the smallest mean decreases were observed in “treatment of “Amputation of toe” (–19%) and “closed treatment of metatarsal fracture” (–7%). Conclusions From 2000 to 2020, Inflation‐adjusted Medicare reimbursement for foot and ankle surgery decreased by 30%. Level of Evidence IV; economic analysis.
Challenges posed by COVID‐19 in cancer patients: A narrative review
Afshar, Zeinab Mohseni , Hosseinzadeh, Rezvan , Barary, Mohammad , Ebrahimpour, Soheil , Alijanpour, Amirmasoud , Hosseinzadeh, Dariush , Miri, Seyed Rouhollah , Sio, Terence T. , Sullman, Mark J. M. , Carson‐Chahhoud, Kristin , Mohseni Afshar, Zeinab , Sayad, Babak , Miri, Seyed Rouhollah , Sio, Terence T , Sullman, Mark J M , Carson-Chahhoud, Kristin , Babazadeh, Arefeh , Barary, Mohammad , Alijanpour, Amirmasoud , Miri, Seyed Rouhollah

Mayo Clinic

Cancer Medicine | December 24, 2021 | Volume: 11 | Issue: 4 | Pages: 1119-1135

10.1002/cam4.4519 | PMID 34951152 Get It

AbstractA novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early 2020, the World Health Organization declared COVID‐19 the sixth public health emergency of international concern. The COVID‐19 pandemic has substantially affected many groups within the general population, but particularly those with extant clinical conditions, such as having or being treated for cancer. Cancer patients are at a higher risk of developing severe COVID‐19 since the malignancy and chemotherapy may negatively affect the immune system, and their immunocompromised condition also increases the risk of infection. Substantial international efforts are currently underway to develop specific methods for diagnosing and treating COVID‐19. However, cancer patients’ risk profiles, management, and outcomes are not well understood. Thus, the main objective of this review is to discuss the relevant evidence to understand the prognosis of COVID‐19 infections in cancer patients more clearly, as well as helping to improve the clinical management of these patients.
Time trend analysis of database and registry use in the neurosurgical literature: evidence for the advance of registry science
Asher, Anthony L. , Sammak, Sally El , Michalopoulos, Giorgos D. , Yolcu, Yagiz U. , Alexander, A. Yohan , Knightly, John J. , Foley, Kevin T. , Shaffrey, Christopher I. , Rose, Geoffrey, Coric, Domagoj , Bisson, Erica F. , Glassman, Steven D. , Mummaneni, Praveen V. , Bydon, Mohamad , Michalopoulos, Giorgos , Alexander, A Yohan , Harbaugh, Robert E. , Rose, Geoffrey A.

Mayo Clinic

Journal of Neurosurgery | December 24, 2021 | Volume: 136 | Issue: 6 | Pages: 1804-1809

10.3171/2021.9.jns212153 | PMID 34920432 Get It

The contributions of survey‐based versus administrative measures of socioeconomic status in predicting type of post‐acute care for hospitalized Medicare beneficiaries
Zhu, Ye , Holmes, George M. , Stearns, Sally C.

Mayo Clinic

Journal of Evaluation in Clinical Practice | December 24, 2021 | Volume: 28 | Issue: 4 | Pages: 569-580

10.1111/jep.13647 | PMID 34940987 Get It

AbstractObjectivesTo assess and compare the associations between socioeconomic status (SES) measures from two sources (claims vs. survey data) and the type of post‐acute care (PAC) locations following hospital discharge.MethodsThis observational study included Medicare Fee‐for‐Service (FFS) beneficiaries age 65.5 years or older who participated in the Medicare Current Beneficiary Survey (MCBS) and were hospitalized in 2006–2011. Multiple data sets were used including: Area Deprivation Index; Medicare Cost Reports, Provider of Services files, and Area Health Resource File. Multinomial regression models estimated associations between beneficiary's SES and PAC type. SES measures came from surveys (income and education) and administrative records (dual enrollment and area deprivation). PAC types included home with self‐care, home health agency, skilled nursing facility (SNF), or inpatient rehabilitation facility.ResultsLow income and dual enrollment were associated with higher SNF use while living in a deprived area was associated with lower SNF use and higher use of home with self‐care. Dual enrollment and area deprivation were associated with the largest differences.ConclusionsIf policies to modify payment based on SES are considered, administrative measures (dual enrollment and area deprivation) rather than survey measures (education and income) may be sufficient.
Skeletal muscle mitochondrial dysfunction and muscle and whole body functional deficits in cancer patients with weight loss
Jatoi, Aminah , Hart, Corey R., Gries, Kevin J. , Kumar, Rajiv , Kunz, Hawley E , Lanza, Ian R , Kumar, Rajiv , Kunz, Hawley , Port, John D. , Kaufman, Kenton R. , Lanza, Ian R.

Mayo Clinic

Journal of Applied Physiology | December 23, 2021 | Volume: 132 | Issue: 2 | Pages: 388-401

10.1152/japplphysiol.00746.2021 | PMID 34941442 Get It

To our knowledge, this is the first study to suggest that skeletal muscle mitochondrial deficits are associated with cancer-associated weight loss in humans. Mitochondrial deficits and alterations in the phospholipid metabolome were concurrent with reductions in whole body and skeletal muscle functional capacity. Whether mitochondrial deficits are causal or secondary to cancer-associated weight loss and functional deficits remains to be determined, but this study supports further exploration of mitochondria as a driver of cancer-associated losses in muscle mass and function.
Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system
Shah, Vishal , Spence, A, Bartels, Trace , Betcher, Jeffrey, Soefje, Scott A. , Soefje, Scott A , Shah, Vishal

Mayo Clinic

American Journal of Health-System Pharmacy | December 23, 2021 | Volume: 79 | Issue: 8 | Pages: 676-682

10.1093/ajhp/zxab479 | PMID 34940791 Get It

Abstract Purpose To decrease drug waste and cost by implementing automated chemotherapy dose rounding rules in the electronic health record (EHR). Dose rounding of chemotherapy is a recognized method for reducing drug waste, and professional organizations have published guidelines recommending dose rounding when possible. Summary On the basis of current literature and guideline recommendations, Mayo Clinic developed system-wide consensus to allow dose rounding for biologic and chemotherapy agents to the nearest vial size if rounding resulted in the dose being within 10% of the originally calculated dose or to a convenient measurable volume, based on concentration of the drug, if rounding to the nearest vial size resulted in the dose being outside the 10% range. Oncology pharmacists reviewed and analyzed all drugs listed in the EHR used in injectable form for the treatment of cancer and developed dose rounding rules. The rules were implemented and applied at the dose calculation stage before provider signature. From January to June 2019, approximately 40,000 cancer treatment doses were administered. The rounding rules saved a total of 9,814 vials of drug, of which 5,329 were for biologic agents and 4,485 were for oncolytic drugs. This resulted in a total 6-month cost savings of $7,284,796 (in 2019 dollars; biologics, $5,727,402; oncolytics, $1,557,394). Conclusion Systematic implementation of dose rounding rules utilizing the EHR can result in significant reduction of drug waste and realization of savings.
Radiomics for Detection of Pancreas Adenocarcinoma on CT Scans: Impact of Biliary Stents
Suman, Garima , Patra, Anurima , Mukherjee, Sovanlal , Korffiatis, Panagiotis , Goenka, Ajit H. , Korfiatis, Panagiotis

Mayo Clinic

Radiology: Imaging Cancer | December 23, 2021 | Volume: 4 | Issue: 1 | Pages: No page available

10.1148/rycan.210081 | PMID 34939849 Get It

Autophagy promotes hepatic cystogenesis in polycystic liver disease by depletion of cholangiocyte ciliogenic proteins
Masyuk, Anatoliy I. , Trussoni, Christy E. , Pirius, Nicholas, Masyuk, Tatyana V. , LaRusso, Nicholas F.

Mayo Clinic

Hepatology | December 23, 2021 | Volume: 75 | Issue: 5 | Pages: 1110-1122

10.1002/hep.32298 | PMID 34942041 Get It

Abstract Backgrounds and Aims Polycystic liver disease (PLD) is characterized by defective cholangiocyte cilia that regulate progressive growth of hepatic cysts. Because formation of primary cilia is influenced by autophagy through degradation of proteins involved in ciliogenesis, we hypothesized that ciliary defects in PLD cholangiocytes (PLDCs) originate from autophagy‐mediated depletion of ciliogenic proteins ADP‐ribosylation factor‐like protein 3 (ARL3) and ADP‐ribosylation factor‐like protein 13B (ARL13B) and ARL‐dependent mislocation of a ciliary‐localized bile acid receptor, Takeda G‐protein‐coupled receptor 5 (TGR5), the activation of which enhances hepatic cystogenesis (HCG). The aims here were to determine whether: (1) ciliogenesis is impaired in PLDC, is associated with increased autophagy, and involves autophagy‐mediated depletion of ARL3 and ARL13B; (2) depletion of ARL3 and ARL13B in PLDC cilia impacts ciliary localization of TGR5; and (3) pharmacological inhibition of autophagy re‐establishes cholangiocyte cilia and ciliary localization of ARL3, ARL3B, and TGR5 and reduces HCG. Approach and Results By using liver tissue from healthy persons and patients with PLD, in vitro and in vivo models of PLD, and in vitro models of ciliogenesis, we demonstrated that, in PLDCs: ciliogenesis is impaired; autophagy is enhanced; ARL3 and ARL13B are ubiquitinated by HDAC6, depleted in cilia, and present in autophagosomes; depletion of ARL3 and ARL13B impacts ciliary localization of TGR5; and pharmacological inhibition of autophagy with mefloquine and verteporfin re‐establishes cholangiocyte cilia and ciliary localization of ARL3, ARL13B, and TGR5 and reduces HCG. Conclusions The intersection between autophagy, defective cholangiocyte cilia, and enhanced HCG contributes to PLD progression and can be considered a target for therapeutic interventions.
Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis
Kostallari, Enis , Wei, Bo , Sicard, Delphine , Li, Jiahui , Cooper, Shawna A. , Gao, Jinhang , Dehankar, Mrunal , Cao, Sheng , Yin, Meng , Tschumperlin, Daniel J. , Shah, Vijay H. , Tschumperlin, Daniel J , Shah, Vijay H , Kostallari, Enis , Yin, Meng , Cooper, Shawna A , Gao, Jinhang , Li, Jiahui , Li, Ying

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 23, 2021 | Volume: 322 | Issue: 2 | Pages: G234-G246

10.1152/ajpgi.00254.2021 | PMID 34941452 Get It

The fibrogenic wound-healing response in liver increases stiffness. Here, macro and microheterogeneity of liver stiffness correlate with HSC heterogeneity in a hepatic fibrosis mouse model. Fibrogenic HSCs localized in stiff collagen-high areas upregulate the expression of focal adhesion molecule FHL2, which, in turn, promotes extracellular matrix protein expression. These results demonstrate that stiffness heterogeneity at the whole organ, lobular, and cellular level drives an amplification loop of fibrogenesis through specific focal adhesion molecular pathways.